HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CD4+ T Cell Help Selectively Enhances High-Avidity Tumor Antigen-Specific CD8+ T Cells.

Abstract
Maintaining antitumor immunity remains a persistent impediment to cancer immunotherapy. We and others have previously reported that high-avidity CD8(+) T cells are more susceptible to tolerance induction in the tumor microenvironment. In the present study, we used a novel model where T cells derived from two independent TCR transgenic mouse lines recognize the same melanoma antigenic epitope but differ in their avidity. We tested whether providing CD4(+) T cell help would improve T cell responsiveness as a function of effector T cell avidity. Interestingly, delivery of CD4(+) T cell help during in vitro priming of CD8(+) T cells improved cytokine secretion and lytic capacity of high-avidity T cells, but not low-avidity T cells. Consistent with this observation, copriming with CD4(+) T cells improved antitumor immunity mediated by higher avidity, melanoma-specific CD8(+) T cells, but not T cells with similar specificity but lower avidity. Enhanced tumor immunity was associated with improved CD8(+) T cell expansion and reduced tolerization, and it was dependent on presentation of both CD4(+) and CD8(+) T cell epitopes by the same dendritic cell population. Our findings demonstrate that CD4(+) T cell help preferentially augments high-avidity CD8(+) T cells and provide important insight for understanding the requirements to elicit and maintain durable tumor immunity.
AuthorsZiqiang Zhu, Steven M Cuss, Vinod Singh, Devikala Gurusamy, Jennifer L Shoe, Robert Leighty, Vincenzo Bronte, Arthur A Hurwitz
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 195 Issue 7 Pg. 3482-9 (Oct 01 2015) ISSN: 1550-6606 [Electronic] United States
PMID26320256 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
CopyrightCopyright © 2015 by The American Association of Immunologists, Inc.
Chemical References
  • Antigens, Neoplasm
  • Epitopes, T-Lymphocyte
Topics
  • Animals
  • Antibody Affinity (genetics, immunology)
  • Antigens, Neoplasm (immunology)
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cell Line, Tumor
  • Cytotoxicity, Immunologic (immunology)
  • Dendritic Cells (immunology)
  • Epitopes, T-Lymphocyte (immunology)
  • Immune Tolerance (immunology)
  • Lymphocyte Activation (immunology)
  • Melanoma (immunology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: